Developing extrachromosomal gene expression vector technologies: an overview. by Wade-Martins, R

Genetics: The MAPT locus-a genetic paradigm in disease susceptibility. by Wade-Martins, R

Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. by Caffrey, T, Wade-Martins, R

A BACwards glance at neurodegeneration: molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice. by Johnson, S, Wade-Martins, R

The role of MAPT sequence variation in mechanisms of disease susceptibility. by Caffrey, T, Wade-Martins, R

Herpes simplex virus type 1 amplicon vectors for the infectious delivery and expression of genomic DNA loci. by Senior, S, Wade-Martins, R

RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. by Fountaine, T, Wade-Martins, R

Familial Alzheimer's disease coding mutations reduce Presenilin-1 expression in a novel genomic locus reporter model. by Ahmadi, S, Wade-Martins, R

High capacity extrachromosomal gene expression vectors. by Hibbitt, O, Wade-Martins, R

Delivery of large genomic DNA inserts >100 kb using HSV-1 amplicons. by Hibbitt, O, Wade-Martins, R

Convergent pathways in Parkinson’s disease by Cherubini, M, Wade-Martins, R

Knock-out and transgenic mouse models of tauopathies. by Denk, F, Wade-Martins, R

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease. by Beevers, J, Caffrey, T, Wade-Martins, R

Parkinson disease, LRRK2 and the endocytic-autophagic pathway. by Alegre-Abarrategui, J, Wade-Martins, R

Delivering RNA interference to the mammalian brain. by Fountaine, T, Wood, M, Wade-Martins, R

Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. by Caffrey, T, Joachim, C, Wade-Martins, R

Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. by Wade-Martins, R, Saeki, Y, Chiocca, E

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease by Keane, H, Whitmore, A, Wade-Martins, R

An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. by Lufino, M, Manservigi, R, Wade-Martins, R

The role of astrocyte dysfunction in Parkinson's disease pathogenesis by Booth, H, Hirst, W, Wade-Martins, R